{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieijxhxiufhtenq6pvhkjgmcy4i4tdtophl7qnajl6ywsyo7tqv3u",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mp75x5vhtev2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicyalakxxzhxjnmnhfgmvedxxu3jpzhlwakkjzmuqgcoqvhrphgzi"
    },
    "mimeType": "image/jpeg",
    "size": 139188
  },
  "path": "/news/2026-06-intravesical-car-therapy-door-bladder.html",
  "publishedAt": "2026-06-26T10:00:06.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells. The study, published in the Journal of Experimental Medicine (JEM), demonstrates that direct delivery of these CAR T cells via a catheter can control bladder tumors in mice, raising hopes that a similar approach may be effective in humans.",
  "title": "Intravesical CAR T therapy opens door to bladder-sparing cancer treatment"
}